Skip to main content

Table 2 Clinical outcomes between acute CVEs group and normal group

From: Predictors of acute cardiovascular events following acute exacerbation period for patients with COPD: a nested case–control study

Outcomes

Acute CVEs group (n = 30)

No CVEs group (n = 466)

P value

Odds ratio

95% CI

Hospital mortality

4/30 (13.3%)

12/466 (2.6%)

0.001

5.821

1.75–19.30

ICU admission

2/30 (6.7%)

26/466 (5.6%)

NS

  

Hospital LOS (d)

14 (12–18)

13 (10–15)

0.022

  

Re-AE at 1 month

8/26 (30.8%)

64/443 (14.5%)

0.025

2.632

1.10–6.31

Accumulative death at 1 month

4/30 (13.3%)

15/455 (3.3%)

0.006

4.513

1.40–14.57

Re-AE at 3 month

14/26 (53.8%)

138/440 (31.4%)

0.018

2.553

1.15–5.67

Accumulative death at 3 month

6/30 (20%)

20/455 (4.4%)

 < 0.001

5.438

1.99–14.79

Re-AE at 6 month

15/24 (62.5%)

195/435 (44.8%)

NS

  

Accumulative death at 6 month

6/30 (20%)

25/455 (5.5%)

0.002

4.30

1.61–11.47

  1. Data were shown as n/N (percentage) or median (IQR). P-values between two group were calculated by Fisher’s exact test, Chi-square test, or Mann–Whitney U test
  2. CVEs cardiovascular events, CI confidence index, ICU intensive care unit, LOS length of stay, AE acute exacerbation